JP Morgan Lifts VRNS Target to $55 on Earnings Day
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Varonis Systems enters today's print with a fresh analyst upgrade in hand, a call-heavy options market, and short sellers still unwinding a position they built months ago.
The most notable development since Friday's preview is JP Morgan's move this morning. Brian Essex raised his price target from $39 to $55, maintaining Overweight — a $16 lift filed on the day of the report itself. That follows a week of broad target increases: Cantor Fitzgerald moved from $35 to $55, B. Riley from $45 to $55, UBS to $58, and Wells Fargo to $50. The consensus mean now runs near $48, already below where several of those targets cluster, which means the Street collectively views the current price of $46.67 as having limited downside even before today's numbers. The stock added 2% on Monday, recovering some of last week's 1.6% slip.
Options traders remain tilted toward calls rather than puts. The put/call ratio has dropped further to 0.51 — more than two standard deviations below its 20-day average of 0.63 — making this one of the most call-skewed readings of the past year. That positioning is not defensive: it reflects a market expecting a beat, not hedging against a miss. Short interest tells a consistent story. Bears have cut their position by roughly 18% over the past month to 6.6% of the float, and borrow availability remains extraordinarily loose at over 3,800% of short interest. There is no squeeze pressure and no sign of fresh conviction on the short side.
The bull case rests on SaaS transition execution: strong ARR growth, high renewal rates, and the emerging AI-driven data security demand that keeps Varonis structurally differentiated from larger platform vendors. Bears flag that the bar has risen sharply — an inflection in this print likely requires a revenue beat of 2-3%, SaaS ARR growth ex-conversions above 26%, and a guidance raise that exceeds the beat itself. At a PE north of 160x and EV/EBITDA near 97x, there is no margin for soft execution. The stock has rallied 16% over the past month. The earnings report will test whether that re-rating was prescient or premature.
Stocks in this article
See the live data behind this article on ORTEX.
Open VRNS on ORTEX →How this article was generated
- Generated
- 28 Jul 2026, 04:28
- Data as of
- 28 Jul 2026, 03:54
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.